Mark Foster

The CurvaFix® IM Implant is the first new intramedullary pelvic trauma technology in 30 years and is the only device capable of following the natural bone shape and filling the space within the pelvis for a wide range of pelvic fracture injuries. Unlike straight screws that cannot follow the natural curvature of intramedullary pathways (limiting use), and bone plates which require an invasive and costly, open surgical procedure, the CurvaFix IM Implant provides a new state-of-the-art option for pelvic fracture fixation. Full functional ownership: R&D, regulatory, quality, manufacturing, supply chain, commercial, finance and HR. Raised capital to fund commercial scale-up, working capital, portfolio development and clinical evidence generation. Lead capital allocation, cash-runway planning and long-range financial strategy with the board. Led development, regulatory execution and commercial launch of the next-generation Low Profile System. Building the clinical evidence and market-development platform for fragility fractures of the pelvis: Managing a complex network of suppliers and contract manufacturers and building the R&D/M&A pipeline for the future.

Field Orthopaedics is a medical device company developing innovative solutions for complex hand fractures, arthritis, and microsurgery, delivering advanced treatment options for hand and upper extremity surgeons.

Robossis will be the first commercially available surgical robot to align long-bone fractures in the large and growing orthopedic medical device market. Robossis enables the surgeon to accurately apply large traction forces, precisely align the fractured bone, and significantly reduce x-ray radiation. As a member of our dynamic group, you will have the unique and rewarding opportunity to shape the future of orthopedic surgeries. Robossis Engineering team is looking for a Robotics Engineer to design, develop and control the Robossis Surgical System. Company Website: Robossis.com

The FDA cleared Saberscope™, is a single–use, fog-free, HD laparoscopic imaging system, which can easily replace expensive, inflexible old school technology to deliver advanced quality surgical care to hundreds of millions of people worldwide.

ZetrOZ Systems is leading healing innovation in sports medicine developing wearable bioelectronic devices for the delivery of sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on proprietary medical technology of +46 patents. The exclusive manufacturer and developer of the sam® product line designed for the treatment of acute and chronic musculoskeletal conditions. Our devices are clinically proven to enhance tissue recovery, accelerate the body’s natural healing processes, and relieve pain.

Venture-backed orthopedic diagnostics and therapeutic extremities company; Raised more than $60M in equity and debt across multiple rounds, and added two public companies — Smith & Nephew and Bioventus — to the cap table and board of directors. Moved the company from a single-product, in-office diagnostic business into a multi-product therapeutic extremities platform. Identified, sourced, financed and closed the acquisitions of SEG-Way Orthopedics and Tenex Health, and integrated both into the commercial organization. Negotiated licensing and international distribution agreements with Boston Scientific, Penumbra, Bioventus, Steris and Clarius, adding non-dilutive revenue and extending the platform into adjacent specialties. Scaled manufacturing and supply chain from one product to a multi-line platform, including the operational integration of two acquired businesses across multiple sites. Led Trice to Great Place to Work certification in 2019..

Trice Medical was founded to fundamentally improve orthopedic diagnostics for the patient, physician, and payor by providing instant, eyes-on, answers. Trice Medical has pioneered fully integrated camera-enabled technology, the mi-eye+, that provides a clinical solution optimized for the physician's office.

Managed US Sports Medicine Business. Was responsible for all Commercial Activities; Including Sales Organization, US Marketing Strategy, Market Development Team, Key Account Managers, Capital Sales Team and ASC Strategic Sales Organization. Full P&L responsibility for the ~$600M US Sports Medicine business: approximately 700 employees and a $130M operating expense budget. Delivered 2015 sales growth of 8% ($34M) and profit growth of 22% ($46M). Accountable for the sales organization, US marketing strategy, market development, key accounts, capital sales and the ASC strategic sales organization. Created and ran the Market Development, Capital Sales, Corporate & Strategic Sales, ASC and Sales Operations functions. Managed pricing, field capital assets and inventory as margin levers. Served on due diligence teams for ArthroCare, Ceterix, Rotation Medical and others.

Managed Eastern half of US Sales Organization with responsibility for Sales Channel, Market Development Team and Key Account Team. US Commercial Lead for Arthrocare Acquisition and Integration. Drove results above budgeted deal model for sales and expense targets. The sales team was a mixture of Independent Distributorships and a Direct Selling Organization with ~200M Revenue and ~230 sales reps. Designed and developed a Market Development Team, which is focused on new product adoption, KOL development and downstream marketing. Designed and implemented Strategic Sales Department - focused on IDN's, GPO's, large conversions and high profile accounts. Designed and implemented Capital Selling Organization- focused on maximizing capital sales set of financial programs to pull through disposable business.

Managed sales organization for Eastern portion of US. The team sells the complete line of Orthopedic Sports Medicine/Arthroscopy products. Products include a mixture of Capital (Video Towers, Instruments, Trays, etc.) and Disposable/Implants. Significant work taking organization from independent to mostly direct - including ROI models, recruiting activities and organizational design. Responsible for MD Relationships, Key Account Coordination, Management Development Programs, Compensation Plan Development, Financial Program Creation, New Product Execution,etc.

Managed Sales Operations, Sales Training and Professional Eduction Training Departments with staffing and P&L responsibilities. Sales Operations: Responsible for GPO analysis, development of financial programs and tracking tools, business analytics, business plan creation, etc. Internal Training Duties : Responsible for designing new hire training programs, web content, literature creation, etc. Professional Education Duties: responsible for KOL management, coordinating MD Fellowship Training program, etc.

Managed a team of 8 sales reps and ~30M in revenue. Products were Gastroenterology, Cardio-Thoracic and Pulmonary. Inducted into Legacy Club (Region Manager Hall of Fame for team's cumulative performance during tenure.) First in BSC history to be inducted into Sales Rep and Manager Legacy Clubs. Additional Responsibilites included project work on the following: Endovations - development of potential go-to-market sales models and ROI tools for disposable endoscope platform. Enteryx - development of ROI models, reimbursement tools and practice building programs for endoluminal treatment of GERD. Significant KOL management, development of financial programs to maximize revenue and share in key accounts.

Managed a territory of >4M of GI,Pulmonary, and Cardio-Thoracic devices. Two- time president's club trip winner, Sales Rep of the Year, Founders Award Winner, Legacy Club (Sales Rep Hall of Fame) inductee.

CT sales rep, formerly known and Kendall Vascular Therapy Division